Please login to the form below

Not currently logged in


This page shows the latest Nanobiotix news and features for those working in and with pharma, biotech and healthcare.

Positive data unlocks more EIB funding for Nanobiotix

Positive data unlocks more EIB funding for Nanobiotix

French biotech Nanobiotix has received a second 14m tranche from a European Investment Bank (EIB) loan, triggered by meeting two development objectives. ... Nanobiotix has previously received 16m from the EIB and can draw on the final 10m by July 2020.

Latest news

  • Nanobiotix signs €40m deal with the EIB Nanobiotix signs €40m deal with the EIB

    loan to fund innovative nanomedicine platform. France's nanomedicine specialist Nanobiotix has secured 40m from the European Investment Bank (EIB) to fund its research. ... Philippe Mauberna, chief financial officer of Nanobiotix, said: “This loan will

  • Lilly closes on first approval for sarcoma drug Lartruvo Lilly closes on first approval for sarcoma drug Lartruvo

    Meanwhile, Nanobiotix filed for approval of its radio-enhancer drug NBTXR3 for STS in Europe last week, while CytRx has an improved doxorubicin candidate called aldoxorubicin in late-stage testing.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Nanobiotix strengthens US leadership team Nanobiotix strengthens US leadership team

    Dr Obrocea (pictured right) joins Nanobiotix as head of US clinical development, bringing 20 years of clinical research leadership to the role. ... Meanwhile, Kurdi (pictured left) becomes director of investor relations at Nanobiotix, moving from the

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company Events and Exhibition Stands is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....